What is LAPSCOVERY? Long Acting Protein / Peptide Discovery Platform Technology
Biologics have a short half-life when administered to the human body. This results in the need for frequent injections and inconvenience to patients. LAPSCOVERY™ (Long Acting Protein/Peptide Discovery) is a platform technology that prolongs the duration of action of biologics and makes it possible for once-weekly or monthly drug administration.
Hanmi’s LAPSCOVERY™ technology prolongs the residence time of a biologic and also minimizes the frequency of treatment and dose required, thereby leading to potential optimized efficacy and reduced adverse events.